About Conference

In the year 2002, Chitkara Educational Trust established its Punjab campus 30 kilometres from Chandigarh, on the Chandigarh–Patiala National Highway. In the year 2010 Chitkara University was established by the Punjab State Legislature under “The Chitkara University Act”.

Chitkara University, the best university in Punjab is a government-recognized university with the right to confer degrees as per the Sections 2(f) and 22(1) of the UGC Act, 1956.

The sprawling campus of the University is equidistant from Chandigarh, Mohali, Panchkula, Ambala and Patiala. The University offers multi-disciplinary programs, all of which are designed to be industry-relevant. As a result of this student-centric approach, Chitkara University is renowned as one of the best private universities in the North India region. From business management programs to programs in nursing and medical laboratory technologies; and from computer science, electronics and mechanical engineering programs, to hotel management and architecture—Chitkara University, Punjab is a veritable cornucopia of educational services.

The Curriculum is delivered in spacious, amphitheatre-style classrooms—fitted with modern information and communication technology (ICT) equipment—and in well-equipped, modern laboratories. Additionally, students are encouraged—and provided relevant facilities—to participate in co-curricular and extra-curricular activities through various clubs and societies on the campus.

It is because of the cumulative effect of an elaborate in-campus academic infrastructure; strong national and international collaborations; and a robust on-campus recruitment record—including regular recruitment by reputed blue-chip companies—that the University finds favor with national as well as international students.

A healthy number of foreign students regularly study at the campus and number of them also visit on exchange programs, adding to the cultural diversity found on campus. The University in Punjab provides several opportunities for local students, too, to visit foreign universities and institutions on such exchange programs, thereby helping them receive invaluable international exposure.

The University has at the centre of its philosophical core the commitment to excellence in education. It is the strong academic heritage of the University, and such firmness on matters of principles that has seen it grow from strength to strength in such a short span of time.

VISION

To be a globally recognized organization promoting academic excellence through interdisciplinary applied research and to expand realms of knowledge through innovation.

MISSION

• To carry out the academic processes in accordance with global standards through active teacher-student-industry participation.
• To promote research, innovation and entrepreneurship in collaboration with industry, research laboratories and academic institutions of global repute.
• To inculcate high moral, ethical and professional values amongst our students, faculty & staff.
• To contribute in building skillful society.

Introduction to Pharmacovigilance

Pharmacovigilance, the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems, is a critical component of healthcare systems worldwide. As the pharmaceutical landscape continues to evolve with the introduction of new drugs and therapies, the importance of robust pharmacovigilance systems has never been greater.

However, despite significant advancements, pharmacovigilance systems globally face numerous challenges. These challenges stem from various factors, including regulatory differences, data quality issues, technological limitations, resource constraints, and the complexities of modern therapies.

Regulatory Differences: The lack of uniform regulations across different countries makes it difficult for pharmaceutical companies to standardize their pharmacovigilance practices. Each region has its own set of guidelines and requirements, which can lead to inconsistencies in adverse event reporting and monitoring.

Data Quality and Standardization: Adverse event data often come from multiple sources and in various formats, posing challenges in data standardization and integration. Incomplete or inaccurate reporting further complicates the assessment of drug safety.

Technology and Infrastructure: Many organizations still rely on legacy systems that are not equipped to handle the increasing volume and complexity of pharmacovigilance data. Integrating these systems with other healthcare information systems is also a significant challenge.

Resource Constraints: Limited resources, particularly in low- and middle-income countries, hinder effective pharmacovigilance activities. There is also a shortage of trained professionals in the field.

Global Surveillance and Data Sharing: Cross-border data sharing is complex due to privacy laws and data protection regulations. Harmonizing data collection and reporting standards globally remains a significant hurdle.

Public and Healthcare Professional Awareness: Underreporting of adverse events is a common issue due to a lack of awareness among healthcare professionals and the public about the importance of reporting drug-related problems.

Timely Detection and Response: Quickly and accurately identifying new safety signals from large datasets and developing effective risk management plans require substantial coordination and resources.

Patient Engagement: Encouraging patients to report adverse events and balancing the need for detailed information with the protection of patient privacy are ongoing challenges.

Complex Therapies: Monitoring the safety of biologics, biosimilars, and combination therapies involves unique challenges compared to traditional drugs. Global Health Crises: Events like the COVID-19 pandemic have highlighted the need for accelerated safety monitoring and reporting, posing additional challenges to existing pharmacovigilance systems.

This conference seeks to address these challenges by providing a platform for stakeholders to share insights, experiences, and strategies. By fostering collaboration and innovation, we aim to enhance global pharmacovigilance practices and ensure the safety and efficacy of medical products for patients worldwide.

Conference Objective

The primary objective of this conference is to bring together key stakeholders from the pharmaceutical industry, regulatory authorities, healthcare providers, and academia to discuss and address the global challenges in pharmacovigilance systems. The conference aims to: